Infertility Treatment Market Size, Share & Trends Analysis Report by IMIR, Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast Till 2034.
Infertility Treatment Market Size, Share & Trends Analysis Report by IMIR, Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast Till 2034.
The global infertility treatment market size was valued at $2.40 billion in 2024 and is expected to grow at a CAGR of 9.2% during the forecast period 2025-2034. Market to Capture $3.65 billion by 2034.
The infertility treatments market is growing steadily. According to one study conducted by the American Society for Reproductive Medicine, more than 5 million Americans alone have been found to live with infertility, although the actual number remains unrevealed. Either male or female infertility can result from a multitude of reasons, though issues related to the reproductive system or both organs are most common. Poor nutrition and stress are some of the factors that could influence sexual health. From research, menopause and other causes have resulted in a greater number of reported cases of female infertility compared to men.
Each year, two to three million barren couples try artificial methods of getting pregnant in India, which means a big business opportunity for pharma companies and diagnostic centers. Even though India has not yet established fertility clinics, it is slowly pacing with other countries such as China and the US. This growing market will benefit pharmaceutical companies that deal in infertility drugs as people who cannot reproduce naturally might turn to potentially beneficial drugs.
Infertility diagnosis is made in about 52% of cases for women and 48% of cases for men. This worldwide industry generates around $15 billion a year without the cost of drugs which is another $4-$5 billion. One out of seven couples in the UK alone access infertility treatment every year, and each successful cycle of treatment yields two children on average, states the HFEA. With reasons such as obesity, stress at work, late marriages, and increasing awareness of issues related to infertility, the figure has increased by 10% in recent years.
As per the European IVF Monitoring (EIM) Report, 60 to 65 percent of all IVF treatments carried out worldwide are conducted in Europe and the US. The report also observes that in the last 10 to 15 years, the volume of procedures performed has grown by over 8% each year, and it estimates that this rate will continue to grow in 2021. 1 to 2 million individuals globally are estimated to have used infertility treatment in 2020, and this figure is expected to grow by about 20–30% each year until 2027.
About 7% of people who are childless in North America are unable to have children. This disease affects up to one in six couples at some time, and it is the single most common reason for consulting a reproduction expert. Estimates suggest that between two and five percent of females in this country have difficulty conceiving or bringing a pregnancy to term. Out of these barren individuals, 25% never consult a physician, 54% do so two years after the fact, and 18% receive therapy in the initial year of trying to conceive.
This has aided the North American treatment market for infertility and is set to continue to do so in the forthcoming years.
The largest growth driver of this market is the growing number of individuals who are willing to conceive later in life. With an increase in life expectancy, so does pregnancy age. Since women are born with a finite supply of eggs, which decreases with age and one of the reasons for declining fertility after the age of 35, this results in more cases of infertility around the world, with women suffering more than men.
Most middle-class couples in developing countries are unable to afford the expense of infertility treatment modalities. The cost of the drugs also is not included, and that too differs depending on the treatment needed and can be as high as $15,000 per cycle and even more.
There are numerous ways of treating infertility.
Each has its own combination of advantages and disadvantages, side effects, cost of treatment, and the rate of success.
A recent market research report added to repository of IMIR Market Research is an in-depth analysis of Global Infertility Treatment Market . On the basis of historic growth analysis and current scenario of Infertility Treatment Market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of global Infertility Treatment Market . This further helps users with their developmental strategy.
This report examines all the key factors influencing growth of global Infertility Treatment Market , including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Infertility Treatment Market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, pricing strategies, innovation possibilities and much more.
The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
Some of the key players in the global infertility treatment market are Merck & Co., Inc., Johnson & Johnson Services, Inc., Ferring Pharmaceuticals A/S, Pfizer, Inc., Bayer AG, Sanofi S.A., and Abbott Laboratories and others.
Asia Pacific to Offer Lucrative Growth Opportunity for Infertility Treatment Market
The growing focus on enhancing healthcare infrastructure is one aspect that differentiates the sector of infertility treatment in Asia from other emerging economies. Also, several factors, including lower cost of operations, international-standard care, and the presence of ancillary facilities for post-operative care, are fueling the growth of the medical tourism industry in emerging economies. Yet, several hurdles deter patients in developing economies from accessing advanced infertility treatment strategies. The key problems that impact installation and penetration of IVF technology are cost factors, consumer unawareness of infertility treatments available, limited insurance coverage for infertility treatment services in these areas, poor infrastructure for conducting diagnostic tests needed to identify cause of infertility in couples, low physician awareness, and absence of sophisticated laboratories for semen analysis.
Asia's infertility treatment market is expected to grow enormously due to the continent's rapid urbanization, growing per capita income, changing lifestyles, and changing traditions. There will be greater funds to offer the medical treatment as the economies of these countries develop. Owing to drivers such as high disposable incomes, increasing health consciousness, growth in the incidence of diseases among the childbearing age group, advances in technology in fertility centers, expansion prospects for IVF centers in major cities, and the introduction of several product initiatives by companies competing in China's infertility treatment market, the nation is projected to have the highest growth prospects among all emerging countries in the infertility treatment market.
India is likely to command a significant share of the Asia Pacific market for infertility treatment, followed by China and other nations. Growing economic development, increasing awareness regarding infertility and the conditions, trend towards wish-child, increasing utilization of sophisticated reproductive technology (RTE) in terms of IVF, pre-conception and prenatal diagnostic centers, enhanced healthcare infrastructure, and launch strategies such as new product launches, partnerships, agreements, collaborations, and expansions are some of the drivers that will fuel growth in this market for India.
Infertility Treatment Market Report is also available for below Regions and Country Please Ask for that
Infertility Treatment Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends:
Want to Review Complete Market Research Report
Customize this Report
Related Reports